Isomorphic Labs to present AI drug design philosophy at NeurIPS 2026
EricBuess · x · 2026-11-06
Isomorphic Labs announced it will appear at NeurIPS 2026 (December, in Sydney, Paris, and Atlanta), unpacking its core technical philosophy: leveraging SOTA agentic models, its conviction in building simulation and world models, and its plan to unlock bottlenecks currently holding AI for biology back.
More from Companies & People
- Anthropic signs first-ever content licensing deal with the AP for election data — ScottNover · 2026-11-06
- Survey of 200 CIOs: Enterprise AI returns concentrate by workload and rise with scale — BenBajarin · 2026-11-06
- Garry Tan amplifies defense of YC: critics are 'out of touch, bitter, or threatened' — garrytan · 2026-11-06
- GPU cloud Lambda rebrands from lambda.ai to lambda.com — TheZachMueller · 2026-11-06
- Microsoft's Katy George on changing how a company the size of Microsoft works with AI — every · 2026-11-06
- OpenAI pledges local residents won't pay electricity costs of its AI data centers — Polymarket · 2026-11-06